Search

We report a novel implantable device that will deliver a tethered aligned collagen guidance conduit containing Schwann cells into a peripheral nerve injury site. Cells (Schwann cells and fibroblasts) incorporated into tethered rectangular collagen gels contracted and resulted in uniaxial alignment. This tissue-engineered construct was tested in three-dimensional culture and demonstrated the ability to guide neurite extension from dissociated dorsal root ganglia. A silicone tube was adapted to provide tethering sites for an implantable construct such that uniaxial cell-generated tension resulted in the formation of a bridge of aligned collagen fibrils, with a resident Schwann cell population. The potential of this device for surgical nerve regeneration was assessed in a 5-mm defect in a rat sciatic nerve model. Neural regeneration through this device was significantly greater than in controls, demonstrating that this system has potential both as a simple robust clinical implant and as a three-dimensional engineered tissue model.

This is a proof of principle report showing that fibres of Bioglass® 45S5 can form a biocompatible scaffold to guide regrowing peripheral axons in vivo. We demonstrate that cultured rat Schwann cells and fibroblasts grow on Bioglass® fibres in vitro using SEM and immunohistochemistry, and provide qualitative and quantitative evidence of axonal regeneration through a Silastic conduit filled with Bioglass® fibres in vivo (across a 0.5 cm interstump gap in the sciatic nerves of adult rats). Axonal regrowth at 4 weeks is indistinguishable from that which occurs across an autograft. Bioglass® fibres are not only biocompatible and bioresorbable, which are absolute requirements of successful devices, but are also amenable to bioengineering, and therefore have the potential for use in the most challenging clinical cases, where there are long inter-stump gaps to be bridged.

Fibronectin mats have proved to be successful guidance substrates for the outgrowth of neurites in models of neural damage. The overall aim of this investigation was to develop a tissue engineering conduit for surgical nerve reconstruction. In this study, fibronectin tubes were developed to provide global guidance for neural regrowth across a short gap. A viscous solution of concentrated plasma fibronectin was obtained from by-products of the human plasma fractionation process. The tube was formed by winding this material around an 18G hypodermic needle and allowing it to dry. The structure and physical properties of the tube were investigated. The spiral-wound material on the needles fused to form a durable tube, whose lumen remained patent after rehydration/swelling in buffer (swelling and stability were characterized). In vivo testing showed growth of axons through the tube 6 weeks post surgery in a rat sciatic nerve injury model. In conclusion, a tube has been developed from fibronectin which can be used to bridge gaps in damaged nerves. This could form the basis for the construction of a surgically implantable device for the tissue engineered repair of peripheral nerve injury.